Position in CYTK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$86,512,319
+$35,231,092 QoQ
Shares Held
1,015,522
+25.8% QoQ
Ownership
0.730%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#35
of 477 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. CYTK ranks #24 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in CYTK
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,512,319 | 1,015,522 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $51,281,227 | 807,070 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $39,121,738 | 1,184,072 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $47,300,374 | 1,176,919 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $46,556,475 | 989,721 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $52,411,233 | 992,637 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $43,325,795 | 799,664 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $68,901,373 | 982,761 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $60,298,899 | 722,229 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $24,437,276 | 829,507 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $24,512,299 | 751,450 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $25,975,815 | 738,159 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $38,459,291 | 839,356 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $39,898,381 | 823,496 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $29,574,918 | 752,734 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $21,952,710 | 596,379 | Shares | Sole | 2023-05-12 | |
| 2020-09-30 | $4,485,880 | 207,200 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $4,883,704 | 207,200 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||